UnitedHealth Group (NYSE:UNH) Given New $463.00 Price Target at Royal Bank Of Canada

UnitedHealth Group (NYSE:UNH) had its price target increased by investment analysts at Royal Bank Of Canada from $400.00 to $463.00 in a report released on Thursday,Benzinga reports. The brokerage currently has an “outperform” rating on the healthcare conglomerate’s stock. Royal Bank Of Canada’s price objective would indicate a potential upside of 7.73% from the company’s current price.

Other research analysts have also issued reports about the stock. Weiss Ratings upgraded shares of UnitedHealth Group from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Thursday, May 7th. Truist Financial increased their price objective on UnitedHealth Group from $395.00 to $440.00 and gave the stock a “buy” rating in a research report on Monday, June 1st. Raymond James Financial upgraded UnitedHealth Group from a “market perform” rating to an “outperform” rating and set a $330.00 target price on the stock in a research report on Wednesday, April 1st. HC Wainwright set a $492.00 price objective on UnitedHealth Group in a research report on Wednesday, May 27th. Finally, Morgan Stanley lifted their price target on shares of UnitedHealth Group from $453.00 to $468.00 and gave the stock an “overweight” rating in a report on Tuesday, June 30th. One investment analyst has rated the stock with a Strong Buy rating, twenty-one have assigned a Buy rating, four have assigned a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $417.38.

UnitedHealth Group Stock Performance

NYSE UNH traded up $4.19 during trading hours on Thursday, hitting $429.79. The company had a trading volume of 1,914,934 shares, compared to its average volume of 8,529,629. UnitedHealth Group has a 1-year low of $234.60 and a 1-year high of $434.30. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.80 and a current ratio of 0.80. The company has a market cap of $390.31 billion, a PE ratio of 32.49, a price-to-earnings-growth ratio of 1.72 and a beta of 0.62. The business has a 50 day moving average of $397.02 and a 200-day moving average of $337.55.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Tuesday, April 21st. The healthcare conglomerate reported $7.23 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $6.76 by $0.47. The firm had revenue of $111.65 billion for the quarter, compared to the consensus estimate of $109.84 billion. UnitedHealth Group had a return on equity of 14.65% and a net margin of 2.68%.The firm’s quarterly revenue was up 2.0% compared to the same quarter last year. During the same quarter last year, the business posted $7.20 EPS. UnitedHealth Group has set its FY 2026 guidance at 18.250- EPS. As a group, equities research analysts expect that UnitedHealth Group will post 18.32 EPS for the current year.

Insider Buying and Selling

In other UnitedHealth Group news, CEO Patrick Hugh Conway sold 800 shares of the company’s stock in a transaction dated Thursday, April 23rd. The shares were sold at an average price of $355.00, for a total value of $284,000.00. Following the completion of the transaction, the chief executive officer directly owned 17,805 shares of the company’s stock, valued at $6,320,775. This represents a 4.30% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. 0.28% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

A number of large investors have recently bought and sold shares of the company. Vanguard Group Inc. raised its stake in UnitedHealth Group by 1.1% during the fourth quarter. Vanguard Group Inc. now owns 91,600,260 shares of the healthcare conglomerate’s stock worth $30,238,162,000 after acquiring an additional 995,210 shares during the period. State Street Corp grew its position in UnitedHealth Group by 2.5% in the 4th quarter. State Street Corp now owns 45,232,170 shares of the healthcare conglomerate’s stock worth $14,931,592,000 after purchasing an additional 1,119,834 shares during the last quarter. Capital World Investors raised its stake in shares of UnitedHealth Group by 3.8% during the fourth quarter. Capital World Investors now owns 22,591,042 shares of the healthcare conglomerate’s stock valued at $7,457,723,000 after purchasing an additional 824,120 shares in the last quarter. Price T Rowe Associates Inc. MD increased its stake in shares of UnitedHealth Group by 3.7% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 18,829,054 shares of the healthcare conglomerate’s stock valued at $6,215,660,000 after acquiring an additional 680,077 shares during the period. Finally, Capital International Investors boosted its stake in UnitedHealth Group by 6.6% during the fourth quarter. Capital International Investors now owns 18,655,111 shares of the healthcare conglomerate’s stock valued at $6,158,734,000 after buying an additional 1,155,162 shares in the last quarter. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group News Summary

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: UnitedHealth is being viewed as a company emerging from a major crisis, and its stock has already recovered sharply since April, suggesting improving investor confidence in the turnaround. UnitedHealth Is Emerging From Its Worst Crisis in Decades. Here’s What History Says Is Coming Next.
• Positive Sentiment: UnitedHealthcare launched a new Lifestyle Spending Account benefit, which could make its employer offerings more attractive and support customer retention and sales. UnitedHealthcare Launches New Spending Account Benefit, Putting More Choice in the Hands of Consumers
• Positive Sentiment: UnitedHealth’s planned $1.5 billion AI investment signals a push to improve automation, digital tools, and long-term operating efficiency, which investors may see as a growth and margin-supportive move. UNH’s $1.5B AI Push: Can It Deliver More Than Cost Savings?
• Neutral Sentiment: UnitedHealth is scheduled to report quarterly earnings Thursday, which keeps attention on near-term results but does not yet provide a clear catalyst by itself. UnitedHealth Group (UNH) to Post Quarterly Earnings on Thursday
• Neutral Sentiment: An external audit found most diagnoses in UnitedHealth senior home visits were supported by medical data, which may help ease some scrutiny around Medicare Advantage practices, but the issue remains a broader regulatory overhang. External audit of UnitedHealth senior home visits finds most diagnoses supported by medical data
• Negative Sentiment: The New York Times reported that UnitedHealth and other insurers are fighting state laws aimed at breaking up pharmacy operations, highlighting continued legal and regulatory pressure on the company’s business model. Health Insurance Giants Are Fighting Efforts to Break Them Up
• Negative Sentiment: One new article argues investors should be cautious on UNH, implying that despite sector growth, UnitedHealth may not be the best healthcare stock to buy right now. Don’t Buy UnitedHealth Group (UNH) Stock Before Reading This

About UnitedHealth Group

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.